NCT03368716

Brief Summary

The purpose of this study is to develop and pilot test a new type of patient-centered, family-based treatment for children aged 8-12 with obesity and their caregivers. The treatment will focus specifically on improving children's self-regulation (SR) skills to help them better manage their feelings, behaviors, and thoughts to help them live a healthier lifestyle.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 11, 2017

Completed
1.2 years until next milestone

Study Start

First participant enrolled

February 4, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

August 31, 2022

Status Verified

August 1, 2022

Enrollment Period

3 years

First QC Date

November 29, 2017

Last Update Submit

August 30, 2022

Conditions

Keywords

Pediatric ObesityExecutive FunctionBehavioral InterventionSelf-RegulationAcceptance-Based

Outcome Measures

Primary Outcomes (16)

  • Change in child body mass index

    Child height and weight measurements will be converted to zBMI using CDC age and sex specific scales.

    Baseline to 4.5 months

  • Change in child objective executive function

    Performance-based EF will be tested using the NIH Toolbox Cognitive Battery which measures executive function (inhibitory control and cognitive flexibility), attention, episodic memory, language, processing speed, and working memory. T-scores will be used for each domain. Higher t-scores indicate better function.

    Baseline to 4.5 months

  • Change in child subjective executive function

    Subjective EF will be measured using the Behavioral Rating Inventory of Executive Function. The Global Severity Index will be used which is interpreted using T-scores. Higher t-scores indicate better function.

    Baseline to 4.5 months

  • Change in Health-Related Quality of Life

    Sizing Me Up© \& Sizing Them Up© are validated obesity-specific self-report and parent-report measures, respectively, of health-related quality of life for children 5-13 years old that measure functioning in a variety of areas (e.g., emotional, physical, teasing/marginalization). The Total Score will be used as the outcome, which is a scaled score ranging from 0-100 with higher scores representing better quality of life.

    Baseline to 4.5 months

  • Cortisol

    ug/dl

    Baseline to 4.5 months

  • Blood pressure

    Systolic over diastolic

    Baseline to 4.5 months

  • Fasting glucose

    mg/dl

    Baseline to 4.5 months

  • Low-density lipoprotein (LDL-C) cholesterol

    mg/dl

    Baseline to 4.5 months

  • High-density lipoprotein (HDL-C) cholesterol

    mg/dl

    Baseline to 4.5 months

  • Triglyceride

    mg/dl

    Baseline to 4.5 months

  • Insulin

    uU/ml

    Baseline to 4.5 months

  • Hemoglobin A1C

    Percentage

    Baseline to 4.5 months

  • Leptin

    ng/mL

    Baseline to 4.5 months

  • Tumor necrosis factor (TNF-a)

    pg/ml

    Baseline to 4.5 months

  • Interleukin (IL-6)

    pg/ml

    Baseline to 4.5 months

  • High-sensitivity reactive protein (hsCRP)

    mg/L

    Baseline to 4.5 months

Secondary Outcomes (8)

  • Child body fat percent

    Baseline to 4.5 months

  • Waist circumference

    Baseline to 4.5 months

  • Child eating behavior

    Baseline to 4.5 months

  • Dietary behavior

    Baseline to 4.5 months

  • Physical activity behavior

    Baseline to 4.5 months

  • +3 more secondary outcomes

Other Outcomes (7)

  • Demographics

    Baseline

  • Participant satisfaction - interviews

    9 weeks, 18 weeks

  • Participant satisfaction - surveys

    9 weeks, 18 weeks

  • +4 more other outcomes

Study Arms (1)

Acceptance-based Behavioral Treatment

EXPERIMENTAL

Family acceptance-based behavioral treatment (ABBT) will be piloted with 16 child-caregiver pairs. At weeks 0 (pre-treatment), 9 (mid-treatment), and 18 (post-treatment), feedback regarding the feasibility and acceptability will be collected from participants through surveys and semi-structured group interviews to refine the family ABBT protocol.

Behavioral: Acceptance-based Behavioral Treatment (ABBT)

Interventions

ABBT is rooted in behavioral therapy but also cultivates self-regulation skills including experiential acceptance of potentially uncomfortable internal experiences (e.g., emotions, cravings), mindful awareness of decision making (e.g., mindful eating), and values clarification and behavioral commitment (e.g., practicing daily physical activity to be a contributing member on a sports team). ABBT has been used effectively to help youth and adults manage various medical and psychological problems. Moreover, components of ABBT have been shown to improve child and adult EF including inhibitory control and cognitive flexibility. Recently, ABBT has been integrated with components of standard behavioral treatment of obesity and applied with robust efficacy to weight management in adults.

Acceptance-based Behavioral Treatment

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • \- Children who: (1) have a BMI ≥ 85th percentile; (2) are ≥8 and ≤12 years old at the beginning of treatment; (3) can read, write, and speak English, along with their caregiver; (4) plan to stay living in the local area during the study period; (5) have a consenting caregiver who can commit to all study procedures and provide reliable travel.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35209, United States

Location

MeSH Terms

Conditions

Pediatric ObesitySelf-Control

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsSocial BehaviorBehavior

Study Officials

  • Marissa A Gowey, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 29, 2017

First Posted

December 11, 2017

Study Start

February 4, 2019

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

August 31, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Given the small number of participants involved in various aspects of the pilot study, we currently do not plan to widely share individual participant data to maximize confidentiality. Individual requests will be considered.

Locations